Search filters

List of works by Raajit K Rampal

Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53

scientific article published on 01 December 2018

Atypical Presentation of Erythroid/Megakaryocytic Leukemic Transformation of a Myeloproliferative Neoplasm Associated with Mutation and Loss of TP53

scientific article published on 15 July 2020

Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial

scientific article published on 06 May 2019

Clinical and molecular genetic characterization of myelofibrosis.

scientific article

Cobimetinib-induced "dropped head syndrome" and subsequent disease management in an Erdheim-Chester patient

scientific article published on 10 September 2019

Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis

scientific article published on 01 November 2020

Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications

scientific article

Finding a needle in a haystack: whole genome sequencing and mutation discovery in murine models ⬇️

scientific article published on March 23, 2011

Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor

scientific article published on 08 September 2020

Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms

scientific article published on 19 October 2017

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis

scientific article published on 06 January 2019

Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting

scientific article published on 10 March 2016

Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis

scientific article published on 28 May 2020

Interferon alpha therapy in essential thrombocythemia and polycythemia vera-a systematic review and meta-analysis

scientific article published on 01 September 2020

Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation

Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations

article

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark

scientific article published on 26 June 2019

Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemia.

scientific article published on 14 July 2016

PRMT5 inhibition modulates E2F1 methylation and gene regulatory networks leading to therapeutic efficacy in JAK2V617F mutant MPN

scientific article published on 15 July 2020

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

scientific article published on 01 October 2020

Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F

scientific article (publication date: 20 November 2015)

Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.

scientific article published on 25 April 2018

Prognostic impact of RAS-pathway mutations in patients with myelofibrosis

scientific article published on 18 October 2019

Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera

scientific article published on 29 May 2020

Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis

scientific article published on 12 November 2019

Risk of disease progression in low-risk MDS is linked to distinct epigenetic subtypes

scientific article published on 22 July 2019

Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis

scientific article published on August 2016

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial

scientific article published on 01 August 2020

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

scientific article published on 18 June 2020

Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia

scientific article published on 13 February 2017

Targeted therapies for myeloproliferative neoplasms

scientific article published on 16 July 2019

Targeting the CALR interactome in myeloproliferative neoplasms

scientific article published on 15 November 2018

The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance

scientific article

Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

scientific article published on 01 January 2019

Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin

scientific article published on 01 November 2020

Paulina is supported by:

About Paulina

Help